Woodline Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Woodline Partners’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-254,334	Closed	-$10.1M	–	709
2024 Q1	$10.1M	Sell	254,334 -745,772	-75%	-$22M	0.09%	268
2023 Q4	$19.1M	Sell	1,000,106 -38,671	-4%	-$537K	0.21%	147
2023 Q3	$11.9M	Buy	1,038,777 +801,213	+337%	+$9.86M	0.14%	203
2023 Q2	$2.44M	Buy	+237,564	New	+$2.14M	0.03%	406

Woodline Partners's ALPN Position: Q2 2024 in Review

Woodline Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 254,334 shares — an estimated $10.1M sold.

Woodline Partners first reported a position in ALPN in Q2 2023 and held it in 4 quarters. The position peaked at $19.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Woodline Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Woodline Partners sold 254,334 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.1M.
Woodline Partners first reported a position in Alpine Immune Sciences Inc in Q2 2023 and held it in 4 quarters.
Woodline Partners's Alpine Immune Sciences Inc position peaked at $19.1M in Q4 2023.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.